Protecting Public Health: Proposed Guidelines for Pharmaceutical Product Distribution

▴ Proposed Guidelines for Pharmaceutical Product Distribution
It is essential for all involved parties to adhere to these guidelines to prevent the introduction of sub-standard products into the market and uphold the highest standards of quality assurance in pharmaceutical distribution.

The Central Drugs Standard Control Organisation (CDSCO) has released draft guidelines aimed at implementing good distribution practices within the pharmaceutical industry to prevent the circulation of spurious, adulterated, and sub-standard products in the market. These guidelines align with the WHO Technical Report Series (TRS) on good storage and distribution practices for pharmaceuticals.

The objective of these guidelines is to establish and maintain a robust quality system throughout the distribution process, from the manufacturer's premises to the end recipient, ensuring the safety and efficacy of pharmaceutical products.

Key Highlights of the Draft Guidelines:

Establishment of Quality System: Pharmaceutical product distributors are mandated to establish and maintain a comprehensive quality system. Each distribution site must appoint a responsible person designated by management to oversee the implementation and maintenance of the quality system.

Documented Procedures and Deviations: The guidelines emphasize the documentation of established procedures and the investigation of any deviations encountered during distribution. Deviations must be appropriately documented and investigated, with corrective and preventive actions (CAPA) implemented to rectify deviations and prevent their recurrence.

Product Recall Procedures: In cases where product recall is necessary, the guidelines stipulate that recalled products must be segregated during transit and clearly labeled as such. If segregation is not feasible during transit, recalled goods should be securely packaged, labeled, and accompanied by appropriate documentation.

Prompt Communication on Product Recall: All customers and competent authorities in countries where the product has been distributed must be promptly informed of any intention to recall a pharmaceutical product.

Disposal of Returned Products: Returned products should be destroyed in accordance with international, national, and local requirements, considering environmental protection. Returned products can only be retained if their quality is confirmed to be satisfactory through a documented and authorized procedure.

Dispatch Records and Traceability: Detailed records of product dispatches must include essential information such as product description, dosage form, strength, quantity, batch number, and expiry date. These records should enable the traceability of pharmaceutical products throughout the distribution process.

The draft guidelines showcases the critical importance of maintaining high standards in pharmaceutical distribution to safeguard public health and safety. By implementing these guidelines effectively, stakeholders across the supply chain can contribute to ensuring the integrity and quality of pharmaceutical products reaching patients and healthcare providers.

It is essential for all involved parties to adhere to these guidelines to prevent the introduction of sub-standard products into the market and uphold the highest standards of quality assurance in pharmaceutical distribution. These measures are imperative in safeguarding public health and maintaining consumer confidence in the pharmaceutical industry.

Tags : #

About the Author


Sunny Parayan

Hey there! I'm Sunny, a passionate writer with a strong interest in the healthcare domain! When I'm not typing on my keyboard, I watch shows and listen to music. I hope that through my work, I can make a positive impact on people's lives by helping them live happier and healthier.

View Profile

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

The Dangers of Ultra-Processed Foods: A Wake-Up Call for Health Conscious IndiansMay 23, 2024
Can Intermittent Fasting Protect Against Liver Cancer? Here’s What the Science SaysMay 23, 2024
Easier, Faster Claims: The Impact of the National Claim Exchange PortalMay 23, 2024
Can Nightmares Predict Autoimmune Flares? Insights from a Groundbreaking StudyMay 23, 2024
Does Parent-Led Singing Improve Development in Preterm Infants? A Comprehensive StudyMay 22, 2024
Biohacking 101: Boosting Physical and Mental Well-beingMay 22, 2024
In a Miraculous Recovery a 13-Year-Old Girl in Delhi Awakens from Coma After Liver Transplant.May 21, 2024
Tackling Hypertension in South-East Asia: A Call to Action on World Hypertension DayMay 20, 2024
FSSAI's Crackdown on Harmful Fruit Ripening Practices: Ensuring Public Health and ComplianceMay 20, 2024
Uncovering the Presence of Microplastics in Human Blood and Their Health EffectsMay 18, 2024
Potential Risks of Meftal: What Consumers and Doctors Should KnowMay 18, 2024
Over-the-Counter Medications in India: A New Era of AccessibilityMay 18, 2024
DCGI Acts Against Overcharging: New Regulations for Blood CentresMay 17, 2024
Cattle as Hosts for Human and Bird Flu Viruses: A Potential Public Health ConcernMay 17, 2024
The Ethics of Live Surgery Broadcasts: NMC Seeks Public OpinionMay 17, 2024
Successful Removal of 3.7 KG Large Abdominal Tumor from 14-Year-Old Somalian Girl at KIMS Cuddles HospitalMay 16, 2024
iLEAD Sets a Precedent by Launching a Graphic Anthology Authored by Multimedia, Animation and Graphics Students May 16, 2024
Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT); Achieves significant advancement in Cancer Treatment to Enhance Quality of LifeMay 16, 2024
IIITH Announces Product Management Summer SchoolMay 16, 2024
Çelebi India's Delhi Cargo Terminal Successfully Handles Airbus H125 Helicopter ShipmentMay 16, 2024